Biosimilars Presbyopia: A part of Aging and Challenges Treatment Option for Ocular Itch

Biosimilars Presbyopia: A part of Aging and Challenges Treatment Option for Ocular Itch

View More Presbyopia Cataract Clinical Diagnosis Cornea DME Dry Eye Glaucoma IOL OCT Ocular Allergy Ocular Surface Disease Pediatrics Ptosis Refractive Retina Technology Therapeutics Understanding Antibiotic Resistance

Presbyopia Cataract Clinical Diagnosis Cornea DME Dry Eye Glaucoma IOL OCT Ocular Allergy Ocular Surface Disease Pediatrics Ptosis Refractive Retina Technology Therapeutics Understanding Antibiotic Resistance

All News Blogs COVID-19

Expert Interviews

Medical World News

Expert Interviews Medical World News Podcasts Viewpoints Insights Eyeviews Case Studies

Health Law & Policy

Personal Finance

Practice Management

Health Law & Policy Money Matters Personal Finance Practice Management

Conference Coverage

Conference Listing

Conference Recaps

Conference Coverage Conference Listing Conference Recaps

Digital Edition

Europe Ophthalmology Times

Supplements and Featured Publications

Digital Edition Europe Ophthalmology Times Modern Retina Supplements and Featured Publications

Partners CME/CE Job Board Sponsored

Print Subscription

eNewsletter Print Subscription

Advertise
Contact Us
Editorial
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Biosimilars
Presbyopia: A part of Aging and Challenges
Treatment Option for Ocular Itch

ClinicalSee All >

Presbyopia
Cataract
Clinical Diagnosis
Cornea
DME
Dry Eye
Glaucoma
IOL
OCT
Ocular Allergy
Ocular Surface Disease
Pediatrics
Ptosis
Refractive
Retina
Technology
Therapeutics
Understanding Antibiotic Resistance

Advertise
Contact Us
Editorial
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences^™ and Ophthalmology Times. All rights reserved.

FDA OKs trabectome glaucoma treatment

April 1, 2004

A new glaucoma treatment from privately held NeoMedix Corp. has received FDA clearance.